AgomAb Therapeutics NV (AGMB) Insider Trading
Sector: Pharmaceuticals · Market Cap: $435M · 1 insider purchase in the last 7 days
| INSIDER | DATE | SHARES | PRICE | TOTAL VALUE | OWNED AFTER | Δ OWNED | FILING |
|---|---|---|---|---|---|---|---|
| Epstein David R Director | Oct 8, 2026 | 5,000 | $8.90 | $45K | 15,000 | +50.0% |
Want more?
Sign up free to see 30+ days of history, set alerts, and track AGMB on your watchlist.
Start for FreeAbout AgomAb Therapeutics NV Insider Trading
3 insiders at AgomAb Therapeutics NV (AGMB) have purchased stock in the past 90 days, totaling $311K across 8 transactions (36,000 shares).
The most recent purchase was by Director Epstein David R on October 8, 2026 — a $45K buy of 5,000 shares at $8.90, bringing his total holdings to 15,000 shares.
Insiders who purchased: Epstein David R (Director, 3 buys totaling $131K); Knotnerus Tim Jasper (CEO, 2 buys totaling $94K); Kemula Pierre Thadee Victor (CFO, 3 buys totaling $86K).
This insider buying is notable given that AGMB had no recorded open market purchases in the nine months before that.
AGMB is in the Pharmaceuticals sector within the Pharmaceuticals industry with a market cap of $435M.
With 3 different insiders buying in the same 90-day window, this qualifies as cluster buying at AGMB — a pattern that research suggests can signal conviction among management.
Track AGMB insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.